Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 46

Results For "EPL"

565 News Found

Over one lakh SARS-CoV-2 genomes sequenced till November
Policy | December 03, 2021

Over one lakh SARS-CoV-2 genomes sequenced till November

Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry


Sygnature Discovery appoints Louisa Jordison as Chief Financial Officer
Appointment | December 01, 2021

Sygnature Discovery appoints Louisa Jordison as Chief Financial Officer

She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature


Conference highlights opportunities in the nursing profession
News | November 30, 2021

Conference highlights opportunities in the nursing profession

This collaborative nursing conference generated a positive dialogue on how the healthcare space of nursing has evolved in the past year


Daiichi Sankyo initiates Phase 3 trial for Destiny-Breast11 neoadjuvant therapy
Biotech | November 30, 2021

Daiichi Sankyo initiates Phase 3 trial for Destiny-Breast11 neoadjuvant therapy

Destiny-Breast11 will evaluate Enhertu as a monotherapy or Enhertu followed by paclitaxel, trastuzumab and pertuzumab


Bharat Biotech commences export of Covaxin
News | November 29, 2021

Bharat Biotech commences export of Covaxin

It’s a two-dose vaccine administered 28 days apart


Organ transplants see a rise in India
Public Health | November 28, 2021

Organ transplants see a rise in India

Maharashtra won the award for the highest number of deceased donors transplantations


NFHS-5 shows momentum towards achieving SDG
News | November 25, 2021

NFHS-5 shows momentum towards achieving SDG

The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues


Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D
News | November 25, 2021

Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D

The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022


ADB approves US $ 1.5 bn for Covid-19 vaccines in India
News | November 25, 2021

ADB approves US $ 1.5 bn for Covid-19 vaccines in India

The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people


U.S. FDA approves first treatment for drug-resistant post-transplant infection
Drug Approval | November 24, 2021

U.S. FDA approves first treatment for drug-resistant post-transplant infection

The approval is for Cytomegalovirus, a type of Herpes virus